Mucosal Melanoma of the Head & Neck

Overview
  • Mucosal melanomas are rare (<1% of all melanomas), but are very aggressive and have features that are distinct from cutaneous melanoma
  • Around 55% of all mucosal melanomas arise within the head and neck region.
    • 2/3 of these arise within the nasal cavity or paranasal sinuses
    • 1/4 arise within the oral cavity
    • The remainder occur sporadically in other sites within the head and neck.
  • Historically, the Ballantyne staging system (1970) was used to classify mucosal melanoma across all sites including outside of the head and neck.
    • The Ballantyne staging system simply classified tumours as Stage I (confined to the primary site), Stage II (regional lymph node involvement), or Stage III (distal metastasis).
  • Mucosal melanomas involving the nasal cavity or paranasal sinuses were also previously staged with the AJCC system for nasal cavity and paranasal sinus carcinoma.
    • However, evidence suggested that this did not discriminate prognosis between stages with mucosal melanoma well.
    • This also did not provide a staging system for MMs of the other potential disease sites in the head and neck.
  • This prompted the creation of a separate staging system for mucosal melanoma involving the head and neck, which was introduced in the AJCC 7th Edition, and remains unchanged in the 8th Edition.
  • Review of results with this new staging system showed good prognostic discrimination between stages and more recent studies (Luna-Ortiz et al) show superior prognostication versus the Ballantyne staging system.
Survival probability over time by stage (AJCC 7th Edition)

Changes from the AJCC 7th Edition
  • Unchanged in the AJCC 8th Edition versus the 7th Edition.
  • However the AJCC 8th Edition was later revised to exclude the dry vermillion lip and oral commissure from this staging system.
    • In the initial version, the dry lip (ie. the vermillion) and oral commissure were considered both mucosal and part of the oral cavity.
    • Melanomas involving the dry lip were staged as mucosal melanomas.
    • Other carcinomas involving the dry lip were staged as oral cavity carcinomas.
  • In the updated AJCC 8th Edition, the dry vermillion lip and oral commissure are no longer considered a mucosal surface and is now grouped with the cutaneous skin.
    • As a result, dry lip melanoma is now staged as a cutaneous melanoma, and other dry lip carcinomas are now staged as cutaneous carcinomas of the head and neck.

T-Categorization
T Category Criteria
T3
  • Limited to the mucosa and underlying soft tissue.
  • No further subdivisions by thickness or dimensions.
T4 Moderately advanced (T4a) or very advanced (T4b) disease
T4a
  • Tumour invasion into the deep soft tissue, cartilage, bone, or overlying skin.
T4b
  • Tumour involvement of the brain, dura, skull base, lower cranial nerves (IX, X, XI, XII), masticator space, carotid artery, mediastinum, or pre-vertebral space.

General Rules

  • There is no T1 or T2 category for mucosal melanoma; all primary tumours are classified as at least T3 due to the aggressive nature of the disease.
  • Primary tumours limited to the mucosa and underlying soft tissue are considered T3.
  • Locally advanced mucosal melanomas are classified as T4a and T4b.
  • Mucosal melanoma in situ is very rare and is excluded from this staging system.

N-Categorization
N Category Criteria
NX

Regional nodes cannot be assessed

N0

Regional lymph node metastasis absent

N1

Regional lymph node metastasis present


M-Categorization
M Category Criteria
M0

No distant metastasis

M1

Distant metastasis present


Group Staging
N0
M0
N1
M0
M1
T3 III IVA IVC
T4a IVA IVA IVC
T4b IVB IVB IVC

General Rules

  • Only T3, N0 is classified as Stage III
  • All T4b tumours are upstaged to Stage IVB (easy to remember).
  • The presence of distant metastasis upstages to Stage IVC
  • Stage IVA is used to classify T3/T4a tumours with regional LN metastasis, as well as T4a tumours without regional LN metastasis.